Day: June 17, 2025

Oryzon’s CSO, Dr. Jordi Xaus, will participate in a Panel entitled “Industry Perspectives Discussion” on June 27 70-90% of PMS patients show autistic related features, including aggression Agitation/Aggression in PMS and other ASD-related patient subpopulations are the main focus of Oryzon’s VANDAM project included in the Med4Cure IPCEI project Oryzon is glad to participate as Sponsor of the congressMADRID and CAMBRIDGE, Mass., June 17, 2025 (GLOBE NEWSWIRE) — Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and a European leader in epigenetics, announced today that its Chief Scientific Officer, Dr. Jordi Xaus will be attending the 2025 Phelan-McDermid Syndrome Congress in Barcelona on June 26-29, which comprises the CureSHANK 2nd Annual Phelan-McDermid Syndrome Drug Development...

BOSTON, June 17, 2025 (GLOBE NEWSWIRE) — Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio” or the “Company”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer, today announced that it will host a virtual key opinion leader (“KOL”) event on Wednesday, June 25, 2025 at 2:00 PM ET to discuss the significant unmet need and current treatment landscape for mutant-KRAS (“mKRAS”) driven pancreatic ductal adenocarcinoma (“PDAC”), one of the most lethal and underserved solid tumors. To register, click here. The event will feature insights from leading experts:Darrell Irvine, Ph.D. – Department of Immunology & Microbiology, The Scripps Research Institute, Howard Hughes Medical Institute Eileen O’Reilly, M.D. – FASCO Gastrointestinal Medical Oncologist at Memorial...

BOCA RATON, Fla., June 17, 2025 (GLOBE NEWSWIRE) — Totaligent, Inc. (OTCPK: TGNT), a leader in digital marketing, today announced a major milestone in its product development journey: the successful onboarding of a new technical leadership team and the adoption of a structured, bi-weekly sprint process. These advancements mark a significant leap forward in Totaligent’s mission to deliver a reliable, modern, and user-centric business intelligence platform. Over the past month, Totaligent has welcomed key engineering hires including a Lead Backend Developer and a Full-Stack Developer with a strong focus on UI/UX. The team has initiated foundational improvements aimed at elevating both the user experience and infrastructure stability. Recent Highlights:Infrastructure Reliability: Critical issues with SMS and email campaign delivery...

ABM Connect™ for Aviation to Elevate Guest Experience and Operational Efficiency Across One of the Busiest U.S. AirportsMIAMI, June 17, 2025 (GLOBE NEWSWIRE) — ABM (NYSE: ABM), a leading provider of facility, engineering, and infrastructure solutions, is proud to announce a new five-year partnership valued at approximately $125 million with Miami-Dade County to provide comprehensive janitorial, smart facility, and integrated maintenance services at Miami International Airport (“MIA”). This agreement includes the full deployment of ABM ConnectTM, the company’s industry-leading technology and data intelligence platform, including the most integrated Smart Restroom monitoring solution ABM has implemented to date. Through this new agreement, ABM will serve as a key partner in supporting MIA’s Modernization in Action (M.I.A.)...

PARIS, June 17, 2025 (GLOBE NEWSWIRE) — CPI Aerostructures, Inc. (“CPI Aero®” or the “Company”) (NYSE American: CVU) announced today that it has signed another Long-Term Agreement (“LTA”) with MST Manufacturing (“MST”) during the international air show in Paris, France, for the supply of components in support of its aerostructures production. This LTA will cover CPI Aero’s requirements from MST through the end of calendar year 2028. “We’ve had a strong relationship with MST and, this second LTA reflects their performance as a critical supplier to CPI Aero, and rewards them for supporting our new programs,” stated Dorith Hakim, president and CEO of CPI Aero. Kenneth Statton, CEO & founder of MST added, “CPI Aero continues to be a strong and reliable part of our business model. We are excited to continue building on our relationship...

ATHENS, Greece, June 17, 2025 (GLOBE NEWSWIRE) — Performance Shipping Inc. (NASDAQ: PSHG), (“we” or the “Company”), a global shipping company specializing in the ownership of tanker vessels, today announced that, through a separate wholly-owned subsidiary, it has entered into a long-term time charter contract with Mercuria Energy Trading S.A. (“Mercuria” or the “Charterer”), for its fourth newbuilding, the previously announced LR1 tanker scheduled for delivery in early 2027. The vessel will be chartered to Mercuria for a firm period of four years, through early 2031, at a daily gross charter rate of US$23,750. The agreement provides Mercuria with options to extend the charter for up to three additional one-year periods. The daily rate will increase by US$850 for each of the first and second optional years and by US$1,200 for the...

DatChat Currently Owns 34% of the AI-generated Publishing Platform and Software Company  NEW BRUNSWICK, N.J., June 17, 2025 (GLOBE NEWSWIRE) — DatChat, Inc. (Nasdaq: DATS) (“DatChat” or the “Company”), a secure messaging and social media company, today announced that its former subsidiary RPM Interactive, an AI-generated publishing and software company, has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (the “SEC”) relating to a proposed initial public offering of shares of its common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined. RPM Interactive has applied to list its common stock on the Nasdaq Capital Market under the ticker symbol “RPMI.” DatChat currently owns 12.5 million shares or approximately...

SOUTH SAN FRANSCISCO, Calif., June 17, 2025 (GLOBE NEWSWIRE) — CERo Therapeutics Holdings, Inc., (Nasdaq: CERO) (“CERo” or the “Company”) an innovative immunotherapy company seeking to advance the next generation of  engineered T cell therapeutics that deploy phagocytic mechanisms, announces that the U.S. Food and Drug Administration (FDA) has granted CERo’s Orphan Drug Designation (ODD) for the company’s lead drug candidate CER-1236, for the treatment of acute myeloid leukemia (AML). CER-1236 is an innovative therapy that engineers a cancer patient’s own T cell therapeutics that deploy phagocytic (i.e., target-cell eating) mechanisms alongside the array of built-in target cell destroying mechanisms used by T cells. CER-1236 is currently in Phase 1 clinical trials for AML. The first-in-human, multi-center, open label,...

WEST PALM BEACH, FLORIDA, June 17, 2025 (GLOBE NEWSWIRE) — FOXO Technologies Inc. (NYSE American: FOXO) (“FOXO” or the “Company”) today announced that its critical access hospital, Big South Fork Medical Center located in Oneida, Tennessee, has commenced offering wound care services to patients both on an inpatient and outpatient basis. The hospital has experienced a growing demand for wound care services in its market service area, particularly for diabetic patients who have wounds often characterized by excessive inflammation and reduced angiogenesis and have a higher risk for postoperative wound healing complications. “We are pleased that our critical access hospital in rural, East Tennessee is expanding its services that will, in turn, increase net revenues and we are working closely with hospital leadership to further expand...

NEW YORK, June 17, 2025 (GLOBE NEWSWIRE) — AMC Networks Inc. (Nasdaq: AMCX) (“AMC Networks” or the “Company”) announced today that it intends to offer, subject to market conditions and other factors, $400 million aggregate principal amount of senior secured notes due 2032 (the “Notes”) in a private offering. The Notes will be unconditionally guaranteed, on a joint and several basis, by each of AMC Networks’ existing and future domestic subsidiaries, subject to certain exceptions, on a senior secured basis. AMC Networks expects to use the net proceeds from the offering of the Notes, together with cash on hand or other immediately available funds, to (i) fund its tender offer (the “Tender Offer”) to purchase for cash up to $450 million aggregate principal amount of its outstanding 4.25% Senior Notes due 2029, (ii) pay related premiums,...